See other companies on Welcome to the Jungle
EvolutionaryScale
Frontier AI models for biology
- 1-20 employees
- Healthcare
- B2B
- Artificial Intelligence
- Biology
- SaaS
- Science
- Civic Center, New York, NY
Jump to section
Company mission
To develop artificial intelligence to understand biology for the benefit of human health and society.
Few candidates hear
back within 2 weeks
Our take
EvolutionaryScale, an AI startup pioneering the 'ChatGPT moment for biology', is at the forefront of transforming the field with its ground-breaking technology. Backed by Amazon Web Services and NVIDIA's venture capital arm, the company aims to revolutionize biology through artificial intelligence.
Central to EvolutionaryScale's mission is ESM3, the first large language model for creating novel proteins. It leverages a vast dataset of nearly 2.8 billion proteins, plus computational tools that analyze protein sequence, structure and function simultaneously. This can help accelerate drug discovery, as well as enable sustainable solutions through engineered microbes.
EvolutionaryScale's approach should help accelerate scientific breakthroughs and enhance precision in biotechnological applications. The company's success hinges on its ethical use of AI to tackle these challenges, by accelerating protein engineering beyond natural evolution so that it can be put to use against our greatest problems.
Steph
Company Specialist at Welcome to the Jungle
Funding (1 round)
Jun 2024
$142m
SEED
Total funding: $142m
This company has top investors
Leadership
Alex Rives
(Co-Founder)Serial Entrepreneur having previously co-founded Kallyope, Syros Pharmaceuticals and Fate Therapeutics. Before founding Evolutionary Scale they worked as a Research Scientist at Facebook AI.
Tom Sercu
(Co-Founder)Previously an Engineering Manager at Meta. Before that they were a Research Engineer at IBM and a Research and Teaching Assistant at New York University.
Articles
Jobs (6)
Software Engineering
People, HR, Recruitment